ADT
33
5
NWL
32
-3
FTI
69
-7
SPG
53
-2
HES
59
3
TDC
47
-2
INTC
37
-4
PWR
60
-2
V
64
-4
PEP
50
-4
WEC
46
-4
VRSN
50
-5
AIG
51
-2
WYNN
34
-3
MNST
52
2
AKAM
56
-2
HSY
38
-2
HPQ
62
2
MSFT
54
-3
KMI
59
2
ADT
33
5
NWL
32
-3
FTI
69
-7
SPG
53
-2
HES
59
3
TDC
47
-2
INTC
37
-4
PWR
60
-2
V
64
-4
PEP
50
-4
WEC
46
-4
VRSN
50
-5
AIG
51
-2
WYNN
34
-3
MNST
52
2
AKAM
56
-2
HSY
38
-2
HPQ
62
2
MSFT
54
-3
KMI
59
2
Financhill
Back

Crinetics Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
50

CRNX
Crinetics Pharmaceuticals

Last Price:
53.91
Seasonality Move:
3%
Sell
26

NBY
NovaBay Pharmaceuticals

Last Price:
0.50
Seasonality Move:
-14.79%
Sell
50
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $52.77. The Score for CRNX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $52.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 52.37 Buy
Chaikin Money Flow: -180916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.4 - 53.78) Buy
Bollinger Bands (100): (45.86 - 53) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: -38478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Buy
Bollinger Bands (100): (0.61 - 3.39) Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.26 Buy
20-day SMA: 52.62 Buy
50-day SMA: 52.35 Buy
200-day SMA: 44.38 Buy
8-day EMA: 52.58 Buy
20-day EMA: 52.32 Buy
50-day EMA: 51.38 Buy
200-day EMA: 44.21 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.89 Sell
200-day SMA: 3.84 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.97 Sell
200-day EMA: 8.42 Sell

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.25 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):